Left ventricular dilatation | |||||
Parameters | Yes (n = 40) | No (n = 25) | p-value | OR | CI (95%) |
Gender | |||||
Male | 27 (67.5%) | 15 (60%) | 0.051 | 2.80 | 0.98 - 7.99 |
Female | 13 (32.5%) | 10 (40%) | 0.001 | 19.5 | 2.19 - 173.5 |
Age range | |||||
<55 years | 25 (62.5%) | 13 (52%) | 0.006 | 4.33 | 1.49 - 12.6 |
≥55 years | 15 (37.5%) | 12 (48%) | 0.016 | 6.87 | 1.27 - 37.15 |
Medical history | |||||
HBP | 10 (25%) | 7 (28%) | 0.001 | 5.21 | 1.94 - 13.99 |
Diabetes | 10 (25%) | 3 (12%) | 0.004 | 23.33 | 1.99 - 273.3 |
Initial nephropathy | |||||
CGN | 21 (52.5%) | 12 (48%) | 0.003 | 5.54 | 1.74 - 17.7 |
Hypertensive nephropathy | 19 (47.5%) | 10 (40%) | 0.059 | 3.8 | 0.91 - 15.78 |
CTIN | 0 (0%) | 3 (12%) | - | - | - |
CKD stage | |||||
GFR < 15 ml/min | 33 (82.5%) | 19 (76%) | 0.001 | 4.34 | 1.72 - 10.96 |
Clinical signs | |||||
Fluid retention | 28 (70%) | 18 (72%) | 0.029 | 3.11 | 1.10 - 8.75 |
TAS ≥ 160 mmHg | 19 (47.5%) | 12 (48%) | 0.010 | 4.49 | 1.38 - 14.57 |
TAD ≥ 100 mmHg | 12 (30%) | 10 (40%) | 0.180 | 2.14 | 0.59 - 7.77 |
Biological signs | |||||
Hb level < 8 g/dl | 25 (62.5%) | 14 (56%) | 0.012 | 3.79 | 1.31 - 11.01 |
Hypocalcemia | 35 (87.5%) | 16 (64%) | 0.000 | 8.02 | 2.73 - 23.6 |
Hyperphosphatemia | 18 (45%) | 14 (56%) | 0.539 | 1.47 | 0.43 - 5.03 |
CRP ≥ 20 mg/l | 32 (80%) | 25 (100%) | 0.006 | 3.6 | 1.41 - 9.61 |